<?xml version="1.0" encoding="UTF-8"?>
<p>MDT-637 (VP-14637) is a fusion inhibitor that has been shown to inhibit RSV entry to the cells. Both 
 <italic>in vitro</italic> reports and preclinical studies in cotton rats demonstrated the anti-RSV activity of MDT-637. This compound is effective against both subtypes of RSV (
 <xref rid="ref81" ref-type="bibr">Kim et al., 2017</xref>). The reformulated form of MDT-637, VP-14637, can be administered by powder inhaler with a quick delivery to the respiratory tract (
 <xref rid="ref165" ref-type="bibr">Wyde et al., 2005</xref>). The results of phase 1 clinical trials indicated a safety and desirable pharmacokinetic profile of the drug in healthy adults (NCT01475305) (
 <xref rid="ref81" ref-type="bibr">Kim et al., 2017</xref>).
</p>
